By How Much Is Kimberly-Clark’s Revenue & EBITDA Expected to Change In The Next 5 Years?

-0.84%
Downside
124
Market
123
Trefis
KMB: Kimberly-Clark logo
KMB
Kimberly-Clark

  • Revenue Growth: 24% driven by expansion in premium Baby Care & At-Home Tissue Products segments
  • EBITDA Growth: 43% driven by revenue growth and margin accretion across-the-board

KMB-5

Have more questions on Kimberly-Clark? See the links below:

Relevant Articles
  1. Should You Pick Kimberly-Clark Stock At $120 After A Downbeat Q4?
  2. Is Kimberly-Clark Stock Fully Priced At $120?
  3. Which Is A Better Pick – Kimberly-Clark Stock Or IDEXX Laboratories?
  4. Which Is A Better Consumer Defensive Pick – Kimberly-Clark Or CL Stock?
  5. Is Kimberly-Clark Stock A Better Pick Over Its Industry Peer?
  6. Steady Revenue Growth Has Not Been Reflected In Kimberly-Clark’s Stock Price – Here’s Why

Notes:

1) The purpose of these analyses is to help readers focus on a few important things. We hope such lean communication sparks thinking, and encourages readers to comment and ask questions on the comment section, or email content@trefis.com
2) Figures mentioned are approximate values to help our readers remember the key concepts more intuitively. For precise figures, please refer to our complete analysis for Kimberly-Clark

Get Trefis Technology